Blood-based proteomic profiling reveals context-dependent changes in BCL2-associated signaling during taxane therapy in breast cancer patients.
Saved in:
| Title: | Blood-based proteomic profiling reveals context-dependent changes in BCL2-associated signaling during taxane therapy in breast cancer patients. |
|---|---|
| Authors: | Munshani S; Department of Pharmacology, Yale School of Medicine, New Haven, CT, USA., Ibrahim EY; Department of Pharmacology, Yale School of Medicine, New Haven, CT, USA., Rodwin RL; Department of Pediatrics (Hematology/Oncology), Yale School of Medicine, New Haven, CT, USA., Ferrucci LM; Department of Chronic Disease Epidemiology and Yale Cancer Center, Yale School of Public Health, New Haven, CT, USA., Blenman K; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA.; Department of Computer Science, School of Engineering and Applied Science, Yale University, New Haven, CT, USA., Lustberg M; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA., Ehrlich BE; Department of Pharmacology, Yale School of Medicine, New Haven, CT, USA. |
| Source: | FEBS open bio [FEBS Open Bio] 2026 Mar 26. Date of Electronic Publication: 2026 Mar 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons Ltd Country of Publication: England NLM ID: 101580716 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-5463 (Electronic) Linking ISSN: 22115463 NLM ISO Abbreviation: FEBS Open Bio Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41883148 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Blood-based proteomic profiling reveals context-dependent changes in BCL2-associated signaling during taxane therapy in breast cancer patients. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Munshani+S%22">Munshani S</searchLink>; Department of Pharmacology, Yale School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Ibrahim+EY%22">Ibrahim EY</searchLink>; Department of Pharmacology, Yale School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Rodwin+RL%22">Rodwin RL</searchLink>; Department of Pediatrics (Hematology/Oncology), Yale School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Ferrucci+LM%22">Ferrucci LM</searchLink>; Department of Chronic Disease Epidemiology and Yale Cancer Center, Yale School of Public Health, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Blenman+K%22">Blenman K</searchLink>; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA.; Department of Computer Science, School of Engineering and Applied Science, Yale University, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Lustberg+M%22">Lustberg M</searchLink>; Department of Medicine (Medical Oncology), Yale School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Ehrlich+BE%22">Ehrlich BE</searchLink>; Department of Pharmacology, Yale School of Medicine, New Haven, CT, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101580716%22">FEBS open bio</searchLink> [FEBS Open Bio] 2026 Mar 26. <i>Date of Electronic Publication: </i>2026 Mar 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons+Ltd%22">John Wiley & Sons Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101580716 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2211-5463 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222115463%22">22115463 </searchLink><i>NLM ISO Abbreviation: </i>FEBS Open Bio <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41883148 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/2211-5463.70239 Languages: – Code: eng Text: English Titles: – TitleFull: Blood-based proteomic profiling reveals context-dependent changes in BCL2-associated signaling during taxane therapy in breast cancer patients. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Munshani S – PersonEntity: Name: NameFull: Ibrahim EY – PersonEntity: Name: NameFull: Rodwin RL – PersonEntity: Name: NameFull: Ferrucci LM – PersonEntity: Name: NameFull: Blenman K – PersonEntity: Name: NameFull: Lustberg M – PersonEntity: Name: NameFull: Ehrlich BE IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 03 Text: 2026 Mar 26 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2211-5463 Titles: – TitleFull: FEBS open bio Type: main |
| ResultId | 1 |